Merrill J. Egorin, MD
Endece Scientific Consultant
Dr. Egorin is a professor in the departments of medicine and pharmacology at the University of Pittsburgh School of Medicine. He has an international reputation for designing drug monitoring and evaluation methods that validate the utility of various medications.
Dr. Egorin received his medical degree and training in internal medicine from Johns Hopkins University school of medicine and hospital. Early in his career, he joined the Baltimore Cancer Research Center, then part of the National Cancer Institute. In 1981, he became a staff physician at the University of Maryland Hospital, where he rose to the position of professor of medicine, pharmacology and experimental therapeutics and oncology. He remains an adjunct professor of medicine there.
Dr. Egorin’s professional affiliations include fellowship in the American College of Physicians and memberships in the American Association for Cancer Research, the American Society for Clinical Oncology, the American Society for Clinical Pharmacology and Therapeutics and the American Society for Pharmacology and Experimental Therapeutics. He serves on the editorial boards of several medical journals and is editor-in-chief of Cancer Chemotherapy and Pharmacology. Dr. Egorin has authored or co-authored numerous book chapters and more than 150 articles in peer-reviewed journals.
